DYAI NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Dyadic International Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 1.05 USD
-11.8% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 21.9% above the Trend Line and sits at 41.8% of its 52-week range. The latest completed week returned -11.8%, after a 11.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is mixed with 39/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal; earnings are due in 11d.

Setup score 47 out of 100
Latest Close 1.05 USD 31 Jul 2026
1W Return -11.8% latest completed week
4W Return 11.6% short-term follow-through
12W Return 37.0% quarterly tape
Trend Breadth 5.8% 3 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • The trend backdrop is active with a 3-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 38.60% based on similar historical setup states.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -11.8% Latest completed week; four-week move 11.6%. Indicator stack 14/100 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 38.60% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Mixed 39/100 conviction; expected move 143.3%. News sentiment 56/100 62 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 21.9% above the Trend Line and sits at 41.8% of its 52-week range. The latest completed week returned -11.8%, after a 11.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.4612-week average 0.19

12-week confirmation

Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership4/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.46Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 11.6% over four weeks, 37.0% over 12 weeks, and 4.5% over one year. The current trend has remained active for 3 consecutive weeks.

Performance by holding period

1W-11.8%
4W11.6%
12W37.0%
26W20.6%
52W4.5%
Active trend streak3 weeks
Active weeks in one year3
Trend breadth5.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.20Latest activity-pressure read.
Pressure change426.6%Four-week change in activity pressure.
Leadership5.13Latest relative-leadership reading.
RS change151.3%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 73% Model confidence 70%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength64/100Blend of value, momentum, and quality. Underlying universe rank 37; rank 1 is best.
Value56/100Relative valuation strength. Underlying universe rank 45; rank 1 is best.
Quality55/100Profitability and accounting quality. Underlying universe rank 46; rank 1 is best.
Momentum56/100Medium-term price momentum. Underlying universe rank 45; rank 1 is best.
Growth56/100Revenue and earnings growth. Underlying universe rank 45; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
14.6x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-13.2%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
31.3%
Gross profit retained from each unit of revenue.
Operating margin
-236.0%
Operating profit retained from revenue.
Free-cash-flow margin
-192.1%
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-11.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
1/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-11.4%
Net share repurchases relative to market value.
Shareholder yield
-11.4%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningMixed

DYAI shows mixed options pressure with a 39/100 conviction score, put-call volume ratio of n/a, expected move of 143.3%, and Sharemaestro trend signal active.

Conviction39/100
Expected move143.3%
Put/call volume
Pressure12
Speculation0
Volatility96
Trend agreement94
Open options detail
Insider activity0 / 3

0 acquisitions and 3 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment56/100

Weighted news tone is neutral across 62 relevant articles.

20 positive · 39 neutral · 3 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
Options expected move143.3%Nearest-chain priced movement where available.
52-week drawdown-34.4%Distance below the 52-week high.
13-week volatility10.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+31.1%Week of 3 Apr.
Worst week-27.8%Week of 27 Mar.
Latest week-11.8%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains2
Flat weeks0
Modest losses8
Sharp losses8
Recent vol10.3%13-week weekly-return volatility.
Base vol10.2%52-week weekly-return volatility.
Up/down split24/28Count of positive and negative weeks in the 52-week window.
Average skew8.6% / -6.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape40/100

Trend, activity pressure, participation, and risk combine to a 40/100 tape read.

 Indicator analysis49/100

Latest 12-week confirmation: trend 3/12, activity pressure 11/12, relative leadership 4/12.

Activity pressure 0.46; No reversal markers Next-Week ExpectancyNegative 38.60%

Next-week expectancy is negative with a 38.60% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors57/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 87 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options59/100

DYAI shows mixed options pressure with a 39/100 conviction score, put-call volume ratio of n/a, expected move of 143.3%, and Sharemaestro trend signal active.

Mixed · Options-market disagreement · Expected move 143.3% Sentiment56/100

Weighted news tone is neutral across 62 relevant articles.

Form 144 Dyadic International Inc For: 21 July By Investing.com Insiders0 / 3

0 acquisitions and 3 disposals in the latest 180-day insider tape.

 Earnings11d

Next report is scheduled for 12 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20261.05 USD-11.8%0.86 USD1.29 USD1.205.13824.3KOn
24 Jul 20261.19 USD-5.6%0.86 USD1.29 USD1.2619.331.5MOn
17 Jul 20261.26 USD18.9%0.85 USD1.30 USD0.9623.991.5MOn
10 Jul 20261.06 USD12.7%0.84 USD1.30 USD0.670.061.6MOff
3 Jul 20260.94 USD17.4%0.84 USD1.31 USD0.23-10.00679.5KOff
26 Jun 20260.80 USD2.4%0.84 USD1.31 USD-0.12-23.071.2MOff
19 Jun 20260.78 USD14.7%0.84 USD1.32 USD0.06-28.92780.1KOff
12 Jun 20260.68 USD-4.0%0.85 USD1.33 USD0.07-36.91732.2KOff
5 Jun 20260.71 USD-12.1%0.85 USD1.34 USD0.16-33.471.1MOff
29 May 20260.81 USD6.4%0.86 USD1.35 USD0.24-28.549.6MOff
22 May 20260.76 USD5.2%0.87 USD1.36 USD0.13-31.69479.1KOff
15 May 20260.72 USD-5.8%0.88 USD1.37 USD0.26-34.98395.2KOff
8 May 20260.77 USD-3.0%0.90 USD1.37 USD0.45-32.02417.8KOff
1 May 20260.79 USD-8.1%0.91 USD1.38 USD0.54-27.07443.4KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.